Urothelial carcinoma of the prostate. 2007

Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain. jpalou@fundacio-puigvert.es

This study was conducted to explore the diagnosis and management of urothelial carcinoma of the prostate in superficial disease and carcinoma in situ, stromal invasion, primary urothelial carcinoma, and urethral recurrence after radical surgery. A consensus conference convened by the World Health Organization (WHO) and the Société Internationale d'Urologie (SIU) reviewed the diagnosis and management of urothelial carcinoma of the bladder. English-language literature about urothelial carcinoma of the prostate was identified and reviewed. Evidence-based recommendations for the diagnosis and management of urothelial carcinoma were made. Many recommendations were level 3 or 4 citations involving the diagnosis and management of superficial urothelial carcinoma; a few were level 2 citations. Level 1 citations related only to chemotherapy and radiotherapy in patients with stromal invasion, although these were not related specifically to invasive prostatic involvement. More than 130 reviewed citations are summarized in this review. Published reports on the diagnosis and treatment of superficial urothelial disease of the prostate primarily consist of short case series from individual centers. Prospective and multicenter trials are needed to identify the real incidence and the best management of these patients. In invasive disease of the prostate, the only large series were designed to investigate invasive bladder cancer.

UI MeSH Term Description Entries
D008297 Male Males
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014943 Global Health A multi- and interdisciplinary field concerned with improving health and achieving equity in health for all people. It transcends national boundaries, promotes cooperation and collaboration within and beyond health science fields, and combines population-based disease prevention with individually-based patient care. International Health Problems,World Health,International Health,Worldwide Health,Health Problem, International,Health Problems, International,Health, Global,Health, International,Health, World,Health, Worldwide,Healths, International,International Health Problem,International Healths,Problem, International Health,Problems, International Health

Related Publications

Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
January 1985, Applied pathology,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
March 1977, Der Urologe. Ausg. A,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
December 2006, Hinyokika kiyo. Acta urologica Japonica,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
July 2010, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
August 2007, The American journal of surgical pathology,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
January 1988, Journal d'urologie,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
January 2019, Medicine,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
September 2016, Journal of pathology and translational medicine,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
March 2007, Expert review of anticancer therapy,
Juan Palou, and Jack Baniel, and Laurence Klotz, and David Wood, and Michael Cookson, and Seth Lerner, and Shigeo Horie, and Mark Schoenberg, and Javier Angulo, and Pierfranco Bassi
July 2016, Urology case reports,
Copied contents to your clipboard!